EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

KNOWLEDGE BANK

TOP ARTICLES

press releases Read more...

XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target

XtalPi HK a leading platform in artificial intelligence AI and roboticsdriven drug discovery today announced a strategic partnership with a prominent international biopharmaceutical company

Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease

Elixiron Immunotherapeutics TPEx a clinicalstage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases today announced positive interim results

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Matisse Pharmaceuticals BV a clinical stage company developing a medicinal product for the treatment of sepsis today announced that the US Food and Drug Administration FDA has granted Fast Track Designation

Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia

Amphista Therapeutics the Company or Amphista a leader in the discovery and development of next generation targeted protein degradation TPD medicines today announces that the US Food and Drug Administration

15 - 18

Jun 2026

MedTech Summit 2026

JW Marriott Hotel Berlin, Berl...

16 - 17

Jun 2026

LogiPharma Asia 2026

Equarius Hotel, Singapore

16 - 18

Jun 2026

CPHI & PMEC China 2026

Shanghai New International Exp...

18 - 20

Jun 2026

CCT 2026

Barcelona, Spain

23 - 24

Jun 2026

24 - 25

Jun 2026

6th Edition Drug Safety Symposium 2026

Courtyard by Marriott, Mumbai,...

25 - 26

Jun 2026

07 - 09

Jul 2026

The Pharma India Expo 2026

Bombay Exhibition Centre, Mumb...

LATEST NEWS Read more...

PharmaEssentia Receives Taiwan Approval for BESREMi in Essential Thrombocythaemia

PharmaEssentia has received approval from Taiwans Ministry of Health and Welfare MOHW for BESREMi ropeginterferon alfabnjft to treat adult patients with essential thrombocythaemia ET

IMAAVY Shows Durable Haemoglobin Response in Phase 2/3 Study for Warm Autoimmune Haemolytic Anaemia

Johnson Johnson has reported positive results from the Phase ENERGY study showing that IMAAVY nipocalimabaahu achieved a statistically significant and durable haemoglobin response in patients with warm

FloBiotech Signs Agreement with UCLA Health to Advance Neurodegenerative Disease Treatments

FloBiotech has entered into an agreement with UCLA Health to support the development of a new class of therapies for neurodegenerative diseases by targeting protective biological pathways involved in disease progression

Engitix and GSK Partner to Advance New Targets for Liver Fibrosis Treatment

Engitix has entered into a strategic research collaboration and option agreement with GSK to identify and validate novel therapeutic targets aimed at promoting liver fibrosis regression

FDA Expands Approval of Pfizer’s HYMPAVZI for Additional Hemophilia A and B Patient Groups

Pfizer has received approval from the US Food and Drug Administration FDA for an expanded indication of HYMPAVZI marstacimabhncq extending its use to patients aged years and older with hemophilia

Teva launches AHZANTIVE biosimilar to Eylea across Europe

Teva Pharmaceutical Industries has launched AHZANTIVE aflibercept a biosimilar to Eylea in Europe expanding its biosimilars portfolio and strengthening its presence in the ophthalmology sector